Diode laser trans-scleral cyclophotocoagulation for glaucoma following silicone oil removal

Atul Kumar, Tanuj Dada, Rajinder P. Singh, Sachin Kedar

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose: To evaluate the effect of trans-scleral cyclophotocoagulation (TSCP) on intraocular pressure (IOP) in eyes with medically uncontrolled secondary glaucoma persisting after intravitreal silicone oil removal. Methods: Clinical records of 21 eyes of 21 patients who underwent TSCP for medically uncontrolled glaucoma persisting after the removal of intravitreal silicone oil, injected during vitreoretinal surgery for proliferative vitreoretinopathy (PVR), were reviewed retrospectively. Diode laser contact TSCP was applied at a power setting of 1.5-2.5 W, for a maximum duration of 2 s, and a total of 40 spots (10 spots each quadrant). All the patients were evaluated for visual acuity, IOP and number of medications used. Results: The patients were followed up for a mean ± SD period of 39.9 ± 4.27 weeks (range 36-48 weeks). The IOP was found to have decreased significantly from a pretreatment value of 34.5 ± 5.37 mmHg (range 24-44 mmHg) to 20.47 ± 4.49 mmHg at 6 months of follow up (range 12-30 mmHg, P < 0.01, Student's paired t-test). The total number of glaucoma medications being used reduced from 3.38 ± 0.5 to 1.08 ± 0.80 postoperatively (P < 0.01, Wilcoxon's rank sum test). There was no significant difference in the visual acuity before and after the procedure. Thirteen eyes required a second sitting of TSCP, and five of these required a third sitting. For a successful outcome (IOP < 24 mmHg), a mean of 1.56 sittings (range 1-3 sittings) per eye were needed. Conclusion: Patients with medically uncontrolled glaucoma persisting after intravitreal silicone oil removal can be treated with TSCP; however, the reduction of IOP is variable. The IOP usually falls after a mean of 2-3 sittings of TSCP.

Original languageEnglish (US)
Pages (from-to)220-224
Number of pages5
JournalClinical and Experimental Ophthalmology
Volume29
Issue number4
DOIs
StatePublished - Sep 8 2001

Fingerprint

Silicone Oils
Semiconductor Lasers
Intraocular Pressure
Glaucoma
Nonparametric Statistics
Visual Acuity
Vitreoretinal Surgery
Proliferative Vitreoretinopathy
Students

Keywords

  • Diode laser
  • Refractory glaucoma
  • Silicone oil-induced glaucoma
  • Trans-scleral cyclophotocoagulation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Diode laser trans-scleral cyclophotocoagulation for glaucoma following silicone oil removal. / Kumar, Atul; Dada, Tanuj; Singh, Rajinder P.; Kedar, Sachin.

In: Clinical and Experimental Ophthalmology, Vol. 29, No. 4, 08.09.2001, p. 220-224.

Research output: Contribution to journalArticle

@article{2014dc98c79341e39d7eda90b2698b28,
title = "Diode laser trans-scleral cyclophotocoagulation for glaucoma following silicone oil removal",
abstract = "Purpose: To evaluate the effect of trans-scleral cyclophotocoagulation (TSCP) on intraocular pressure (IOP) in eyes with medically uncontrolled secondary glaucoma persisting after intravitreal silicone oil removal. Methods: Clinical records of 21 eyes of 21 patients who underwent TSCP for medically uncontrolled glaucoma persisting after the removal of intravitreal silicone oil, injected during vitreoretinal surgery for proliferative vitreoretinopathy (PVR), were reviewed retrospectively. Diode laser contact TSCP was applied at a power setting of 1.5-2.5 W, for a maximum duration of 2 s, and a total of 40 spots (10 spots each quadrant). All the patients were evaluated for visual acuity, IOP and number of medications used. Results: The patients were followed up for a mean ± SD period of 39.9 ± 4.27 weeks (range 36-48 weeks). The IOP was found to have decreased significantly from a pretreatment value of 34.5 ± 5.37 mmHg (range 24-44 mmHg) to 20.47 ± 4.49 mmHg at 6 months of follow up (range 12-30 mmHg, P < 0.01, Student's paired t-test). The total number of glaucoma medications being used reduced from 3.38 ± 0.5 to 1.08 ± 0.80 postoperatively (P < 0.01, Wilcoxon's rank sum test). There was no significant difference in the visual acuity before and after the procedure. Thirteen eyes required a second sitting of TSCP, and five of these required a third sitting. For a successful outcome (IOP < 24 mmHg), a mean of 1.56 sittings (range 1-3 sittings) per eye were needed. Conclusion: Patients with medically uncontrolled glaucoma persisting after intravitreal silicone oil removal can be treated with TSCP; however, the reduction of IOP is variable. The IOP usually falls after a mean of 2-3 sittings of TSCP.",
keywords = "Diode laser, Refractory glaucoma, Silicone oil-induced glaucoma, Trans-scleral cyclophotocoagulation",
author = "Atul Kumar and Tanuj Dada and Singh, {Rajinder P.} and Sachin Kedar",
year = "2001",
month = "9",
day = "8",
doi = "10.1046/j.1442-9071.2001.00431.x",
language = "English (US)",
volume = "29",
pages = "220--224",
journal = "Clinical and Experimental Ophthalmology",
issn = "1442-6404",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Diode laser trans-scleral cyclophotocoagulation for glaucoma following silicone oil removal

AU - Kumar, Atul

AU - Dada, Tanuj

AU - Singh, Rajinder P.

AU - Kedar, Sachin

PY - 2001/9/8

Y1 - 2001/9/8

N2 - Purpose: To evaluate the effect of trans-scleral cyclophotocoagulation (TSCP) on intraocular pressure (IOP) in eyes with medically uncontrolled secondary glaucoma persisting after intravitreal silicone oil removal. Methods: Clinical records of 21 eyes of 21 patients who underwent TSCP for medically uncontrolled glaucoma persisting after the removal of intravitreal silicone oil, injected during vitreoretinal surgery for proliferative vitreoretinopathy (PVR), were reviewed retrospectively. Diode laser contact TSCP was applied at a power setting of 1.5-2.5 W, for a maximum duration of 2 s, and a total of 40 spots (10 spots each quadrant). All the patients were evaluated for visual acuity, IOP and number of medications used. Results: The patients were followed up for a mean ± SD period of 39.9 ± 4.27 weeks (range 36-48 weeks). The IOP was found to have decreased significantly from a pretreatment value of 34.5 ± 5.37 mmHg (range 24-44 mmHg) to 20.47 ± 4.49 mmHg at 6 months of follow up (range 12-30 mmHg, P < 0.01, Student's paired t-test). The total number of glaucoma medications being used reduced from 3.38 ± 0.5 to 1.08 ± 0.80 postoperatively (P < 0.01, Wilcoxon's rank sum test). There was no significant difference in the visual acuity before and after the procedure. Thirteen eyes required a second sitting of TSCP, and five of these required a third sitting. For a successful outcome (IOP < 24 mmHg), a mean of 1.56 sittings (range 1-3 sittings) per eye were needed. Conclusion: Patients with medically uncontrolled glaucoma persisting after intravitreal silicone oil removal can be treated with TSCP; however, the reduction of IOP is variable. The IOP usually falls after a mean of 2-3 sittings of TSCP.

AB - Purpose: To evaluate the effect of trans-scleral cyclophotocoagulation (TSCP) on intraocular pressure (IOP) in eyes with medically uncontrolled secondary glaucoma persisting after intravitreal silicone oil removal. Methods: Clinical records of 21 eyes of 21 patients who underwent TSCP for medically uncontrolled glaucoma persisting after the removal of intravitreal silicone oil, injected during vitreoretinal surgery for proliferative vitreoretinopathy (PVR), were reviewed retrospectively. Diode laser contact TSCP was applied at a power setting of 1.5-2.5 W, for a maximum duration of 2 s, and a total of 40 spots (10 spots each quadrant). All the patients were evaluated for visual acuity, IOP and number of medications used. Results: The patients were followed up for a mean ± SD period of 39.9 ± 4.27 weeks (range 36-48 weeks). The IOP was found to have decreased significantly from a pretreatment value of 34.5 ± 5.37 mmHg (range 24-44 mmHg) to 20.47 ± 4.49 mmHg at 6 months of follow up (range 12-30 mmHg, P < 0.01, Student's paired t-test). The total number of glaucoma medications being used reduced from 3.38 ± 0.5 to 1.08 ± 0.80 postoperatively (P < 0.01, Wilcoxon's rank sum test). There was no significant difference in the visual acuity before and after the procedure. Thirteen eyes required a second sitting of TSCP, and five of these required a third sitting. For a successful outcome (IOP < 24 mmHg), a mean of 1.56 sittings (range 1-3 sittings) per eye were needed. Conclusion: Patients with medically uncontrolled glaucoma persisting after intravitreal silicone oil removal can be treated with TSCP; however, the reduction of IOP is variable. The IOP usually falls after a mean of 2-3 sittings of TSCP.

KW - Diode laser

KW - Refractory glaucoma

KW - Silicone oil-induced glaucoma

KW - Trans-scleral cyclophotocoagulation

UR - http://www.scopus.com/inward/record.url?scp=0034859163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034859163&partnerID=8YFLogxK

U2 - 10.1046/j.1442-9071.2001.00431.x

DO - 10.1046/j.1442-9071.2001.00431.x

M3 - Article

C2 - 11545419

AN - SCOPUS:0034859163

VL - 29

SP - 220

EP - 224

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

SN - 1442-6404

IS - 4

ER -